Subscribe to our latest updates, reports and upcoming events. Subscribe >
From To
Subscribe to our latest updates, reports and events.
SubscribeShowing 1 - 10 of 1605
Sort by
Case review 2021-01-15
Our previous article considered the High Court’s decision in Rowe & Ors v Ingenious Media Holdings plc & Ors. The Court of Appeal (CoA) has now provided guidance on when a court should exercise its discretion to require a voluntary cross-undertaking in damages as a condition of requiring a claimant or their commercial litigation funder to provide security for costs.
Case review 2021-01-14
Ohoud Al-Najar (by her litigation friend, Khadia Al-Mulla) and others v The Cumberland Hotel (London) Limited [18.12.20]: The appellants’ claim was advanced on the basis that the owner of the hotel had broken the duty “to take such care as in all the circumstances of the case was reasonable to see that [the Appellants] person and property were kept reasonably safe, whilst they were staying at the hotel”. Some 30 allegations of negligence were advanced against the hotel relating to the adequacy of security arrangements.
Report 2021-01-12
Advances in genomics are turbocharging the global response to the COVID-19 pandemic and continuing to redefine how we understand healthcare.
Article 2021-01-12
Modern slavery has become a growing concern for businesses across all sectors, becoming an issue insurers are taking seriously.
Article 2021-01-12
After several years of careful consideration by review committees, key stakeholder groups and the subsequent preparation by the legislature of legislation, pre-action protocols in clinical negligence claims are yet to be introduced in Ireland. Despite the Legal Services (Regulation) Act coming into force in 2015, commencement of section 219 of the Act - the final step required for the drafting of the necessary regulations to formally introduce the pre-action protocols - has not been commenced.
Article 2021-01-11
In a statement made today, the Lord Chancellor and Secretary of State for Justice has confirmed that implementation of the Whiplash Reform Programme has been pushed back to May 2021.
Article 2021-01-08
After such a challenging 2020, all businesses are craving more certainty in the new year. Whilst 2021 is already producing its own surprises, there is at least some certainty in the legal and regulatory issues likely to affect insurers and intermediaries in the UK. This article summarises key issues insurers and intermediaries should keep clearly on the radar in 2021.
Report 2021-01-06
Our research identified five key risk themes that have implications and represent both challenges and opportunities for businesses, insurers, and wider society. This will assist in moving the conversation forward as we look beyond COVID-19, highlighting the important need to reshape the dynamic relationship between companies, households, and insurers.
Article 2021-01-05
In early December 2020, the UK government announced with considerable fanfare its approval of Pfizer/BioNTech’s COVID-19 vaccine. Around 40 million doses were ordered, and the UK’s mass vaccination programme commenced in December 2020, with the US, Canada, Bahrain and Saudi Arabia close behind. On 30 December 2020, the Oxford AstraZeneca vaccine received UK approval with the first doses administered in early January.
Article 2020-12-29
The legal technology market has a natural fascination for the new. Words like “launches”, “debuts”, “unveils” are the narrative that propels a growing niche of alternative offerings that are increasingly an adjunct to most big firms.
